000			02268 a2200673 4500
005			20250517102654.0
264		0	_c20180105
008			201801s 0 0 eng d
022			_a1096-1186
024	7		_a10.1016/j.phrs.2016.06.016 _2doi
040			_aNLM _beng _cNLM
100	1		_aMaldonado-Montoro, Mar
245	0	0	_aGenetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis. _h[electronic resource]
260			_bPharmacological research _c09 2016
300			_a264-271 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Humanized _xadverse effects
650	0	4	_aAntigens, CD _xgenetics
650	0	4	_aAntigens, Differentiation, T-Lymphocyte _xgenetics
650	0	4	_aAntirheumatic Agents _xadverse effects
650	0	4	_aArthritis, Rheumatoid _xblood
650	0	4	_aChi-Square Distribution
650	0	4	_aFemale
650	0	4	_aGene Frequency
650	0	4	_aGenome-Wide Association Study
650	0	4	_aHeterozygote
650	0	4	_aHomozygote
650	0	4	_aHumans
650	0	4	_aLectins, C-Type _xgenetics
650	0	4	_aLinear Models
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aN-Acetylgalactosaminyltransferases _xgenetics
650	0	4	_aOdds Ratio
650	0	4	_aPharmacogenetics
650	0	4	_aPharmacogenomic Testing
650	0	4	_aPharmacogenomic Variants
650	0	4	_aPhenotype
650	0	4	_aPredictive Value of Tests
650	0	4	_aRecovery of Function
650	0	4	_aRemission Induction
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
650	0	4	_aPolypeptide N-acetylgalactosaminyltransferase
700	1		_aCañadas-Garre, Marisa
700	1		_aGonzález-Utrilla, Alfonso
700	1		_aPlaza-Plaza, José Cristian
700	1		_aCalleja-Hernández, Miguel Ÿngel
773	0		_tPharmacological research _gvol. 111 _gp. 264-271
856	4	0	_uhttps://doi.org/10.1016/j.phrs.2016.06.016 _zAvailable from publisher's website
999			_c26157129 _d26157129